News

DEFUSE 3 Terminated Early with High Likelihood of Benefit in the Endovascular Group

Following an interim analysis of data from the first 182 patients enrolled in DEFUSE 3, the trial has been terminated and is no longer actively enrolling patients. The interim analysis showed a high likelihood of benefit in the endovascular group of the study.

New Technology to Treat Strokes Debuts in Colorado

St. Anthony is the first hospital in Colorado to get the RAPID technology to treat strokes. The hospital is considered a comprehensive stroke center by the American Heart and Stroke Associations.

iSchemaView Rapid for Stroke at Memorial Regional

RAPID is the automated Stroke Analysis system used in the Stryker clinical trial, DAWN. We are evaluating whether stroke patients presenting in late time windows can be effectively treated.

Stanford Pioneers New Brain Imaging to Improve Stroke Care

The Stanford Stroke Center has pioneered the use of brain imaging that is changing the way doctors treat stroke. Called multimodal imaging, these views of the brain capture what tissue can be saved—even though a patient might have had a stroke several hours after the three-hour window now seen as the standard end of useful intervention. Learn More >

NUH doctors use AI to identify stroke patients within a minute to give timely life-saving treatment

National University Hospital is first in Singapore to adopt RapidAI software that has been clinically validated in multi-site clinical trials